Úr myrkri vanþekkingar til  vísindarannsókna og inn í ljós klínískrar tilrauna -

Samantektar fyrirlestur á alheimsráðstefnu Retina International í Stresa á Ítalíu 26 & 27 júní 2010 

Lesa meira

How many times in the last week have you heard the terms, "accountability," "documentation," "measurement," "evidence," "goals," or "objectives"? In both education and rehabilitation, our work increasingly follows a precise model of planning, instruction, and evaluation to verify effectiveness.

Lesa meira

This series of reports is based on presentations by scientists and scientist/clinicians at the ARVO 2010 Annual Meeting (“The Future of Eye and Vision Research”), in Ft. Lauderdale, Florida, held from May 2 – 6, 2010.  There were uncountable numbers of opportunities to glean new information about retinal degenerative diseases and to learn about new devices and approaches for detecting and treating each.

 

Lesa meira

TORONTO, May 26 /CNW/ - A new study led by Dr. Robert Koenekoop at the Montreal Children's Hospital at the McGill University Health Centre holds promise for certain patients with Leber congenital amaurosis (LCA), an inherited retinal degenerative disease that causes significant vision loss from birth.Útdráttur Lesa meira

Hér má sjá viðtal við Dr. Gerald Chader sem er einn virtasti vísindamaður heims sem fæst við rannsóknir á augnsjúkdómnum RP eða Retinitis Pigmentosa.

Lesa meira

Niðurstaða fengin í samkeppni AMD Alliance International um gerð fræðslumyndbands um AMD (ellihrörnun í augnbotnum).  

Lesa meira

REUTLINGEN, Germany--(BUSINESS WIRE)--Retina Implant, AG, a leading developer of subretinal implants for the visually impaired, today announced scientific revelations discovered during the company's first human clinical trial. The results achieved in the 11 patients that were involved in the trial exceeded the company's expectations for their first trial.

Lesa meira

Researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts have developed a new tool for gene therapy that significantly increases gene delivery to cells in the retina compared to other carriers and DNA alone, according to a study published in the January issue of The Journal of Gene Medicine.

Lesa meira

Hér fer þýðing á grein úr tímariti norsku blindrasamtakanna „Norges blinde“ frá 17.desember 2009 eftir Ingunn Saltbones Leini

Lesa meira

Eye surgeons at Manchester Royal Eye Hospital have implanted an intraocular electronic retinal prosthesis or 'bionic eye' in two Manchester patients who became blind due to advanced retinitis pigmentosa – an inherited and degenerative disease of the retina. 

Lesa meira

The reports below were prepared exclusively for Retina International. They are based on presentations made by scientists and clinicians at the Twelfth Annual Vision Conference (“Mechanisms of Macular Degeneration”) and the ARVO 2009 Annual Meeting, in Ft. Lauderdale, Florida, held consecutively from May 1 – 7, 2009.

Lesa meira

Fréttatilkynning frá bandaríska fyrirtækinu Neurotech þar sem greint er frá fyrstu niðurstöðum í klínískum lyfjatilraunum við að finna meðferð við Retinitis Pigmentosa (RP) 

Lesa meira

Second Sight® Medical Products, Inc., sem er leiðandi fyrirtæki í þróun  á rafeindasjón fyrir blinda, hefur tilkynnt að það ætli að auka við fjölda þeirra einstaklinga sem taka þátt í prófunum á ArgusTM II, rafeindasjónbúnaðinum, í tilraunarstöðvum fyrirtækisins í Evrópu.

Lesa meira

Fundargerð Vísinda og ráðgjafarnefndar Retina International, sem haldinn var mánudaginn 4 maí, á ársfundi AVRO í Fort Lauderdale í Bandaríkjunum.

Lesa meira

March 4, 2009 – Leading vision researchers from across Canada are embarking on a five-year, $2.4 million collaborative project to develop stem cell therapies to reverse blindness. Canada’s largest private charity for vision research, the Foundation Fighting Blindness, is partnering with the Canadian Institutes of Health Research to fund the program. The research team includes seven principal scientists led by Dr. Valerie Wallace, Senior Scientist at the Ottawa Health Research Institute (the research arm of The Ottawa Hospital) and Associate Professor at the University of Ottawa.

Lesa meira

Bandaríska fyrirtækið Neurotech hefur fengið leyfi bandarískra yfirvalda (FDA) fyrir byltingakenndum tilraunir á sjúklingum til meðferðar á RP og ellihrörnun í augnbotnum (Dry AMD). 

Lesa meira